Status:
UNKNOWN
A Registry Study of Biomarkers in Progression of Acute Heart Failure(BIOMS-POAHF)
Lead Sponsor:
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18-80 years
Brief Summary
The registry study aims to discover the prognostic value of bio-markers in acute heart failure
Eligibility Criteria
Inclusion
- 1\. Patients aged greater than or equal to 18 years with acute exacerbation of chronic heart failure or new heart failure
- 2\. With typical symptoms of acute heart failure as follows: Dyspnea, ankle swelling and fatigue (Limited activity endurance), increased jugular pressure, rales and peripheral edema ;
- 3\. Plasma concentrations of BNP: BNP\>100pg/ML
- 4\. Echocardiography: Related structural heart disease (left ventricular hypertrophy and/or left atrial enlargement) and/or diastolic dysfunction
Exclusion
- 1\. Previous history of cancer or renal replacement therapy
- Surgery was performed within a month
- Accompanied by cardiogenic shock, sepsis, pneumonia
- Eligible patients without informed consent form
Key Trial Info
Start Date :
December 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT04108182
Start Date
December 1 2015
End Date
October 1 2025
Last Update
September 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, China, 100029